Abstract

Quinolones are among the prominent class of broad-spectrum antibiotics. In this work, a series of 1,4-dihydro-4-oxo-3-[3-{benzenesulfon}-2-hydrazino-1-oxo-]quinoline derivatives 6a-e were synthesized and tested for their antibacterial efficacy in vitro. Compounds 6a-e were characterized by NMR (1H,13C), HRMS and IR analysis. All these compounds confirmed bactericidal activity against tested bacterial strains. The MIC data have shown that compounds 6e (MIC = 7.5 mg/mL) displayed better activity against Staphylococcus aureus, Escherichia coli (ETEC) and Pseudomonas aeruginosa. Compounds 6b-e (MIC = 7.5 mg/mL) have similar activity as Norfloxacin against E. coli. Molecular docking studies was also conducted to explore binding interactions of our compounds at the active sites of the GyrB subunit of E. coli K-12.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.